Advertisement

Value of Waist Circumference in Metabolic Diseases

  • V. Saroja Voruganti
  • Anthony G. Comuzzie
Chapter

Abstract

Obesity is a global health problem affecting adults, adolescents, and children alike. It has reached epidemic proportions in the United States with approximately 34% of adults classified as clinically obese and additional 34% overweight. Abdominal obesity, characterized by excess visceral fat, is associated with an increased risk for several metabolic diseases including type 2 diabetes, cardiovascular disease, and metabolic syndrome. Imaging modalities are the best measures for abdominal obesity, but are not always feasible in clinical settings. Waist circumference is an anthropometric measurement that is easy, cost effective, informative, and well suited for assessment in nearly all clinical settings. It is strongly correlated with, and used as a surrogate marker for, abdominal fat mass and has been associated with all-cause mortality. Increased waist circumference is closely associated with alterations in carbohydrate and lipid metabolism as well as inflammation and atherosclerosis. Other metabolic diseases such as asthma, sleep apnea, and certain types of cancer have also been associated with an increase in waist circumference. In addition, a larger waistline is generally associated with an overall decrease in cardio-respiratory and general physical fitness and health-related quality of life. In conclusion, waist circumference is an easily obtainable measure that can be used to quickly assess an individual’s susceptibility to cardiometabolic disease risk.

Keywords

Waist Circumference Abdominal Obesity Visceral Adipose Tissue High Waist Circumference Increase Waist Circumference 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Abbreviations

ApoB

Apolipoprotein B

BMI

Body mass index

CRP

C-reactive protein

CVD

Cardiovascular disease

GLUT4

Glucose transporter 4

HDL

High-density lipoprotein

ICAM 1

Intercellular adhesion molecule 1

IDF

International Diabetes Federation

IL6

Interleukin 6

IRS-2

Insulin receptor substrate-2

LDL

Low-density lipoprotein

NHLBI

National Heart, Lung and Blood Institute

PAI-1

Plasminogen activator inhibitor 1

T2DM

Type 2 diabetes mellitus

TNF α

Tumor necrosis factor alpha

VLDL

Very low-density lipoprotein

WHR

Waist to hip ratio

References

  1. Akinpelu AO, Akinola OT, Gbiri CA. Adiposity and quality of life: a case study from an urban center in Nigeria. J Nutr Educ Behav. 2009;41:347–52.PubMedCrossRefGoogle Scholar
  2. Alonso AL, Munguia-Miranda C, Ramos-Ponce D, Hernandez-Saavedra D, Kumate J, Cruz M. Waist perimeter cutoff points and prediction of metabolic syndrome risk. A study in a Mexican population. Arch Med Res. 2008;39:346–51.PubMedCrossRefGoogle Scholar
  3. Aronne LJ. Classification of obesity and assessment of obesity-related health risks. Obes Res. 2002;10:105S–115S.PubMedCrossRefGoogle Scholar
  4. Biovin A, Brochu G, Marceau S, Marceau P, Hould FS, Tchernof A. Regional differences in adipose tissue metabolism in obese men. Metabolism. 2007;56:533–40.CrossRefGoogle Scholar
  5. Bosello O, Zamboni M. Visceral obesity and metabolic syndrome. Obes Rev. 2000;1:47–56.Google Scholar
  6. Burns SF, Arslanian SA. Waist circumference, atherogenic lipoproteins, and vascular smooth muscle biomarkers in children. J Clin Endocrinol Metab. 2009;94:4914–922.PubMedCrossRefGoogle Scholar
  7. Cote N, Pibarot P, Pepin A, Fournier D, Audet A, Arensault B, Couture C, Poirier P, Despres JP, Mathieu P. Oxidized low-density lipoprotein, angiotensin II and increased waist circumference are associated with valve inflammation in prehypertensive patients with aortic stenosis. Int J Cardiol. 2009; [Epub ahead of print].Google Scholar
  8. Despres JP, Lemieux I, Prud’homme D. Treatment of obesity: need to focus on high risk of abdominally obese patients. BMJ. 2001;322:716–820.PubMedCrossRefGoogle Scholar
  9. Despres JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 2006;444:881–7.PubMedCrossRefGoogle Scholar
  10. Engeli S, Bohnke J, Gorzelniak K, Janke J, Schling P, Bader M, Luft FC. Sharma AM. Weight loss and the rennin-angiotensin-aldosterone system.Hypertension. 2005;45:356–62.PubMedCrossRefGoogle Scholar
  11. Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999–2008. JAMA. 2010;303:235–41.PubMedCrossRefGoogle Scholar
  12. Ginsberg HN. Treatment for patients with metabolic syndrome. Am J Cardiol. 2003;91 [suppl]:29E–39E.PubMedCrossRefGoogle Scholar
  13. Gomez-Ambrosi J, Pastor C, Salvador J, Silva C, Rotellar F, Gil MJ, Catalan V, Rodriguez A, Cienfuegos JA, Fruhbeck G. Influence of waist circumference on the metabolic risk associated with impaired fasting glucose: effect of weight loss after gastric bypass. Obes Surg. 2007;17:585–91.PubMedCrossRefGoogle Scholar
  14. Gustafson B, Gogg S, Hedjazifar S, Jenndahl L, Hammarstedt A, Smith U. Inflammation and impaired adipogenesis in hypertrophic obesity in man. Am J Physiol Endocrinol Metab. 2009;297:E999–E1003.PubMedCrossRefGoogle Scholar
  15. Han JH, Park HS, Shin CI, Chang HM, Yun KE, Cho SH, Choi EY, Lee SY, Kim JH, Sung HN, Kim JH, Choi I, Yoon YS, Lee ES, Song HR, Bae SC. Metabolic syndrome and quality of life (QOL) using generalized and obesity-specific QOL scales. Int J Clin Pract. 2009;63:735–41.PubMedCrossRefGoogle Scholar
  16. Han TS, van Leer EM, Seidell JC, Lean MEJ. Waist circumference action levels in the identification of cardiovascular risk factors: prevalence study in a random sample. BMJ. 1995;311:1401–5.PubMedCrossRefGoogle Scholar
  17. Jakobsen MU, Berentzen T, Sorensen TIA, Overvad K. Abdominal obesity and fatty liver. Epidemiol Rev. 2007;29:77–87.PubMedCrossRefGoogle Scholar
  18. Klein S. Outcome success in obesity. Obes Res. 2001;9:354S–8S.PubMedCrossRefGoogle Scholar
  19. Klein S, Allison DB, Heymsfield SB, Kelley DE, Leibel RL, Nonas C, Kahn R Association for Weight Management and Obesity Prevention; NAASO, The Obesity Society; American Society for Nutrition; American Diabetes Association. Waist circumference and cardiometabolic risk: a consensus statement from Shaping America’s Health: Association for Weight Management and Obesity Prevention; NAASO, The Obesity Society, the American Society for Nutrition; and the American Diabetes Association. Am J Clin Nutr. 2007;85:1197–202.PubMedGoogle Scholar
  20. Kressel G, Trunz B, Bub A, Hulsmann O, Wolters M, Lichtinghagen R, Stichtenoth DO, Hahn A. Systemic and vascular markers of inflammation in relation to metabolic syndrome and insulin resistance in adults with elevated atherosclerosis risk. Atherosclerosis. 2009;201:263–71.CrossRefGoogle Scholar
  21. Lean MEJ, Han TS, Morrison CE. Waist circumference as a measured for indicating need for weight management. BMJ. 1995;311:158–61.PubMedCrossRefGoogle Scholar
  22. Lear SA, Chen MM, Frohlich JJ, Birmingham CL. The relationship between waist circumference and metabolic risk factors: Cohorts of European and Chinese descent. Metabolism. 2002;51:1427–32.PubMedCrossRefGoogle Scholar
  23. Lee E, Lee S, Park Y. n-3 polyunsaturated fatty acids and trans fatty acids in patients with the metabolic syndrome: a case-control study in Korea. Br J Nutr. 2008;100:609–14.PubMedCrossRefGoogle Scholar
  24. Lee S, Bacha F, Gungor N. Arslanian SA Waist circumference is an independent predictor of insulin resistance in black and white youths. J Pediatr. 2006;148:188–94.PubMedCrossRefGoogle Scholar
  25. Lemieux I, Pascot A, Couillard C, Lamarche B, Tchernof A, Alméras N, Bergeron J, Gaudet D, Tremblay G, Prud’homme D, Nadeau A, Després JP. Hypertriglyceridemic waist: A marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small dense LDL) in men? Circulation. 2000;102:179–84.PubMedCrossRefGoogle Scholar
  26. Lewis GF. Steiner G. Acute effects of insulin in the control of VLDL production in humans. Implications for the insulin-resistant state. Diabetes Care. 1996;19:390–3.PubMedCrossRefGoogle Scholar
  27. Mathieu P, Poirier P, Pibarot P, Lemieux I, Despres JP. Visceral obesity: the link among inflammation, hypertension, and cardiovascular disease. Hypertension. 2009;53:577–84.PubMedCrossRefGoogle Scholar
  28. Moliner-Urdiales D, Ruiz JR, Vicente-Rodriguez G, Ortega FB, Rey-Lopez JP, España-Romero V, Casajús JA, Molnar D, Widhalm K, Dallongeville J, González-Gross M, Castillo MJ, Sjöström M, Moreno LA. Associations of muscular and cardiorespiratory fitness with total and central body fat in adolescents: The HELENA study. Br J Sports Med. 2009, l Aug 19 [Epub ahead of print].Google Scholar
  29. Musaad SM, Patterson T, Ericksen M, Lindsey M, Dietrich K, Succop P, Khurana Hershey GK. Comparison of anthropometric measures of obesity in childhood allergic asthma: central obesity is most relevant. J Allergy Clin Immunol. 2009;123:1321–7.PubMedCrossRefGoogle Scholar
  30. PI-Sunyer FX. The obesity epidemic: Pathophysiology and consequences of obesity. Obes Res. 2002;10:97S–104S.PubMedCrossRefGoogle Scholar
  31. Poirier P, Despres JP. Waist circumference, visceral obesity and cardiovascular risk. J Cardiopulmonary Rehab. 2003;23:161–9.CrossRefGoogle Scholar
  32. Postorino M, Marino C, Tripepi G, Zoccali C. Abdominal obesity and all-cause and cardiovascular mortality in end-stage renal disease. J Am Coll Cardiol. 2009;53:1265–72.PubMedCrossRefGoogle Scholar
  33. Sabir N, Sermez Y, Kazil S, Zancir M. Correlation of abdominal fat accumulation and liver steatosis: importance of ultrasonographic and anthropometric measurements. Eur J Ultrasound. 2001;14:121–8.PubMedCrossRefGoogle Scholar
  34. Sakuragi S, Abhayaratna K, Gravemaker KJ, O’Reilly C, Srikusanukul W, Budge MM, Telford RD. Abhayaratna WP. Influence of adiposity and physical activity on arterial stiffness in healthy children: the lifestyle of our kids study. Hypertension 2009;53:611–6.PubMedCrossRefGoogle Scholar
  35. Schinner S, Scherbaum WA, Bornstein SR, Barthel A. Molecular mechanisms of insulin resistance. Diabet Med. 2005;22:674–82.PubMedCrossRefGoogle Scholar
  36. Seidell JC, Perusse L, Despres JP, Bouchard C. Waist and hip circumferences have independent and opposite effects on cardiovascular disease risk factors: the Quebec Family Study. Am J Clin Nutr. 2001;74:315–21.PubMedGoogle Scholar
  37. Steffen LM, Vessby B, Jacobs Jr DR, Steinberger J, Moran A, Hong C-P, Sinaiko AR. Serum phospholipid and cholesterol ester fatty acids and estimated desaturase activities are related to overweight and cardiovascular risk factors in adolescents. Int J Obes. 2008;32:1297–304.CrossRefGoogle Scholar
  38. Steffen A, Schulze MB, Pischon T, Dietrich T, Molina E, Chirlaque MD, Barricarte A, Amiano P, Quiros JR, Tumino R, Mattiello A, Palli D, Agnoli C, Misirli G, Boffeta P, Kaaks R, Rohrmann S, Bueno-de-Mesquita HB, Peeters PH, May AM, Spencer FA, Allen NE, Bingham S, Tjonneland A, Halkjaer J, Overvad K, Stegger J, Manjer J, Lindkvist B, Hallmanns G, Stenling R, Lund E, Riboli E, Gonzalez CA, Boeing H. Anthropometry and esophageal cancer risk in the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev. 2009;18:2079–89.PubMedCrossRefGoogle Scholar
  39. St-Pierre J, Lemieux I, Vohl MC, Perron P, Tremblay G, Despres JP, Gaudet D. Contribution of abdominal obesity and hypertriglyceridemia to impaired fasting glucose and coronary artery disease. Am J Cardiol. 2002;90:15–8.PubMedCrossRefGoogle Scholar
  40. Teichtahl AJ, Wang Y, Wluka AE, Szramka M, English DR, Giles GG, O’Sullivan R, Cicuttini FM. The longitudinal relationship between body composition and patella cartilage in healthy adults. Obesity. 2008;16:421–7.PubMedCrossRefGoogle Scholar
  41. Thoenes M, Reil JC, Khan BV, Bramlage P, Volpe M, Kirch W, Bohm M. Abdominal obesity is associated with microalbuminuria and an elevated cardiovascular risk profile in patients with hypertension.Vasc Health Risk Manag. 2009;5:577–85.PubMedGoogle Scholar
  42. Thomson RL, Buckley JD, Moran LJ, Noakes M, Clifton, PM, Norman, RJ, Brinkworth, GD. Comparison of aerobic exercise capacity and muscle strength in overweight women with and without polycystic ovary syndrome. Int J Obstetrics Gynecol. 2009;116:1242–50.Google Scholar
  43. Vega GL. Cardiovascular outcomes for obesity and metabolic syndrome. Obes Res. 2002;10:27S–32S.PubMedCrossRefGoogle Scholar
  44. Von Behren J, Lipsett M, Horn-Ross PL, Delfino RJ, Gillilan F, McConnell R, Bernstein L, Clarke CA, Reynolds P. Obesity, waist size, and prevalence of current asthma in the California Teachers Study Cohort. Thorax. 2009; [Epub ahead of print].Google Scholar
  45. Wahrenberg H, Hertel K, Leijonhufvud BM, Persson LG, Toft E, Arner P. Use of waist circumference to predict insulin resistance: retrospective study. BMJ. 2005;330:1363–4.PubMedCrossRefGoogle Scholar
  46. Warnberg J, Nova E, Moreno LA, Romeo J, Mesana MI, Ruiz JR, Ortega FB, Sjostrom M, Bueno M. Marcos A, and the AVENA study group. Inflammatory proteins are related to total and abdominal adiposity in a healthy adolescent population: the AVENA Study. Am J Clin Nutr. 2006;84:505–12.PubMedGoogle Scholar
  47. Wei YF, Wu HD, Chang CY, Huang CK, Tai CM, Hung CM, Tseng WK, Wu CC. The impact of various anthropometric measurements of obesity on pulmonary function in candidates for surgery. Obes Surg. 2009 [Epub ahead of print].Google Scholar
  48. Weinbrenner T, Schroder H, Escurriol V, Fito M, Elosua R, Vila J, Marruget J, Covas M. Circulating oxidized LDL is associated with increased waist circumference independent of body mass index in men and women. Am J Clin Nutr. 2006;83:30–5.PubMedGoogle Scholar
  49. Yalcin BM, Sahin EM, Yalcin E. Which anthropometric measurements is most closely related to elevated blood pressure? Fam Pract. 2005;22:541–7.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  1. 1.Department of GeneticsTexas Biomedical Research InstituteSan AntonioUSA

Personalised recommendations